AMPK activation has been reported to promote the translocation of the insulin-sensitive GLUT4 pool (33), which would enhance insulin action independently of changes in insulin signal transduction and should be further explored in individuals with obesity. Here, SLC2A4 is linked to obesity due to melanocortin 4 receptor deficiency.